#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sickle cell anaemia Small cell lung cancer Fusarium infection Transferrin decreased Carcinoid syndrome Immunoglobulin G4 related disease Nephrotic syndrome Mastocytosis Hypochondroplasia Anti-myelin-associated glycoprotein associated polyneuropathy Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Graft versus host disease Alveolar proteinosis Antithrombin III deficiency Small intestine adenocarcinoma More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Trials in Disease Leiomyosarcoma – Treatment Hypereosinophilic syndrome – Basic Information Activated PI3 kinase delta syndrome – Trials in Disease Basal cell naevus syndrome Rosai-Dorfman syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Trials in Disease Uterine leiomyosarcoma – Diagnostics Hyperoxaluria – Diagnostics Paroxysmal nocturnal haemoglobinuria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mercaptamine Plerixafor Sodium Iotalamate (125I) ADCE-D01 Betula Alba Pollen Extract GSKVX000000034797 SEPOFARSEN GSK3862995B Clozapine Enfortumab Vedotin Ketoprofen Lysine Sodium Cromoglicate ABIRATERONE DECANOATE Maralixibat Chloride Imipenem Metoclopramide Hydrochloride Gadoteridol Adezunap Treprostinil Palmitil Propranolol Hydrochloride More therapies…

    Learn about Your Condition

    Pemphigus Oesophageal achalasia Injection site pain Polycystic ovarian syndrome Cognitive disorder Spinal pain Urinary incontinence Gaucher's disease type III Ovarian cancer Implantation complication Urethral stenosis Procedural headache Complex regional pain syndrome Synovial sarcoma CDKL5 deficiency disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Health Care Economics and Organizations

  • Study of nirsevimab and RSV vaccine (Abrysvo) for prevention of respiratory syncytial virus infection in infants during their first year of life

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchiolitis
    • Respiratory syncytial virus infection
    France

  • Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • HUMAN MENOPAUSAL GONADOTROPHINS
    • Letrozole
    The Netherlands

  • Study on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma recurrent
    • Bladder transitional cell carcinoma stage 0
    • Bladder transitional cell carcinoma stage I
    Investigated Drugs:
    • Hexaminolevulinate
    Italy

  • Study on Decitabine and Drug Combination for Elderly Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Dabrafenib
    • Decitabine
    • Hydroxycarbamide
    Norway

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!